Login / Signup

Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria.

Kelly A HagadornMary E PetersonHemanta KoleBethany ScottJeff SkinnerAbabacar DioufEizo TakashimaAissata OngoibaSafiatou DoumboDidier DoumtabeShanping LiPadmapriya SekarMei YanChengsong ZhuHikaru NagaokaBernard N KanoiQuan-Zhen LiCarole LongEric O LongKassoum KayentaoScott A JenksIgnacio SanzTakafumi TsuboiBoubacar TraoreSilvia BollandKazutoyo MiuraPeter D CromptonChristine S Hopp
Published in: Immunity (2024)
Many infections, including malaria, are associated with an increase in autoantibodies (AAbs). Prior studies have reported an association between genetic markers of susceptibility to autoimmune disease and resistance to malaria, but the underlying mechanisms are unclear. Here, we performed a longitudinal study of children and adults (n = 602) in Mali and found that high levels of plasma AAbs before the malaria season independently predicted a reduced risk of clinical malaria in children during the ensuing malaria season. Baseline AAb seroprevalence increased with age and asymptomatic Plasmodium falciparum infection. We found that AAbs purified from the plasma of protected individuals inhibit the growth of blood-stage parasites and bind P. falciparum proteins that mediate parasite invasion. Protected individuals had higher plasma immunoglobulin G (IgG) reactivity against 33 of the 123 antigens assessed in an autoantigen microarray. This study provides evidence in support of the hypothesis that a propensity toward autoimmunity offers a survival advantage against malaria.
Keyphrases
  • plasmodium falciparum
  • multiple sclerosis
  • immune response
  • dendritic cells
  • genome wide
  • free survival